NCT00274248
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
NCT00274248
NCT00599937
Not specified
NCT00090090
NCT00591526
Not specified
NCT00116467
NCT00041990
NCT00552825
NCT00535912
Not specified
NCT00537550
NCT00514969